Security and aerospace company Northrop Grumman (NYSE: NOC) fell short of the market’s revenue expectations in Q3 CY2025 as sales rose 4.3% year on year to $10.42 billion. The company’s full-year revenue guidance of $41.8 billion at the midpoint came in 0.9% below analysts’ estimates. Its GAAP profit of $7.67 per share was 18.7% above analysts’ consensus estimates.

Is now the time to buy NOC? Find out in our full research report (it’s free for active Edge members).

StockStory’s Take

Northrop Grumman’s third quarter reflected steady operational execution but fell short of Wall Street’s revenue expectations, with management attributing the results to strong demand across defense programs and ongoing investments in production capacity. CEO Kathy Warden pointed to “mid-single-digit growth, expanded segment operating margin, and a 72% increase in free cash flow year over year,” emphasizing robust order activity and backlog growth despite delayed program awards. Warden acknowledged some headwinds related to timing of contract awards and continued challenges in the company’s space segment, but highlighted that international sales grew 32% and operational improvements drove higher earnings per share.

Looking ahead, Northrop Grumman’s updated guidance is shaped by expectations of continued growth in all four business segments, supported by ongoing investments in manufacturing capacity and technology. Management highlighted that potential acceleration of B-21 bomber production and new missile defense contracts could further bolster results if finalized. Warden noted, “We remain focused on executing our programs and delivering on our commitments,” while CFO Ken Crews reaffirmed the company’s aim to maintain segment operating margin and grow free cash flow. However, the outlook remains sensitive to the timing of government contract awards and potential impacts from U.S. budget negotiations.

Key Insights from Management’s Remarks

Management identified strong order activity, international momentum, and operational efficiencies as key drivers of the quarter, while program award delays and segment-specific headwinds impacted top-line growth.

• International sales acceleration: Northrop Grumman’s international business grew 32% in the quarter, with management noting increased demand from allied nations seeking air and missile defense modernization. Warden emphasized that “allies are prioritizing investments in air and missile defense, ground-based ISR, and advanced weapons systems.”
• Missile defense and B-21 progress: The company achieved milestones such as the second B-21 aircraft entering flight tests, and secured a multibillion-dollar contract extension for the Ground-based Midcourse Defense Weapon System. These programs are seen as critical growth drivers, with Warden highlighting successful integration of new technologies and ongoing discussions with the U.S. Air Force on accelerating B-21 production.
• Operational efficiency gains: Mission Systems delivered double-digit sales growth and a 300 basis point margin improvement, attributed to efficiency initiatives, higher factory utilization, and risk mitigation on advanced microelectronics programs. Crews noted these efforts resulted in a “$68 million favorable EAC adjustment.”
• Backlog and capacity investments: Backlog increased 7.6% year over year, and management highlighted above-industry-average capital investment aimed at expanding production capacity for munitions, microelectronics, and satellites. These investments are expected to position the company for long-term demand growth.
• Segment-specific challenges: Space Systems sales remained pressured by the wind-down of two large programs, but management believes this headwind is nearly lapped. Delayed timing on certain awards in Aeronautics also weighed on revenue, but was characterized as a matter of timing rather than lost sales.

Drivers of Future Performance

Northrop Grumman expects growth in defense demand, major program ramp-ups, and operational efficiencies to shape its outlook, while remaining cautious about contract award timing and government funding uncertainties.

• Defense demand remains elevated: Management sees sustained demand for advanced defense systems and modernization efforts both in the U.S. and internationally, which is expected to drive mid-single-digit sales growth across all segments next year. Warden emphasized bipartisan support for defense spending as a key pillar for long-term growth.
• Potential B-21 and missile defense upside: Acceleration of B-21 bomber production and new contract wins in missile defense, such as IBCS and Golden Dome-related programs, could provide incremental upside. However, management cautioned that these opportunities are not yet included in current guidance, and their margin contribution in early phases could be limited due to development and ramp-up costs.
• Risks from award timing and budget: Delays in government contract awards, a possible extended U.S. budget impasse, and supply chain constraints (notably rare earth materials for microelectronics) are key risks. Management stated that prolonged delays could impact cash flow and near-term sales, but noted existing mitigation strategies, including domestic sourcing for microelectronics.

Catalysts in Upcoming Quarters

In the coming quarters, our analysts will focus on (1) the pace of contract awards and government funding resolutions, (2) the ramp-up and operational milestones for B-21 and major missile defense programs, and (3) evidence of international order growth and backlog conversion. Execution on capacity expansion, supply chain resilience, and successful integration of new technologies will also be critical for tracking Northrop Grumman’s progress against its long-term strategy.

Northrop Grumman currently trades at $595, down from $602.50 just before the earnings. Is there an opportunity in the stock?The answer lies in our full research report (it’s free for active Edge members).

Stocks That Trumped Tariffs

Trump’s April 2025 tariff bombshell triggered a massive market selloff, but stocks have since staged an impressive recovery, leaving those who panic sold on the sidelines.

Take advantage of the rebound by checking out our Top 6 Stocks for this week. This is a curated list of our High Quality stocks that have generated a market-beating return of 183% over the last five years (as of March 31st 2025).

Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,545% between March 2020 and March 2025) as well as under-the-radar businesses like the once-small-cap company Exlservice (+354% five-year return). Find your next big winner with StockStory today.

StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here.